
BMO Capital Keeps Their Buy Rating on AMN Healthcare Services (AMN)

BMO Capital analyst Jeffrey Silber has reaffirmed a Buy rating on AMN Healthcare Services (AMN) with a price target of $22.00 as of November 7. Silber, who specializes in the Consumer Defensive sector, has an average return of 6.0% and a 54.07% success rate. Additionally, Citizens JMP's Constantine Davides also issued a Buy rating on the same day, while Benchmark Co. maintained a Hold rating on AMN.
BMO Capital analyst Jeffrey Silber maintained a Buy rating on AMN Healthcare Services on November 7 and set a price target of $22.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Silber covers the Consumer Defensive sector, focusing on stocks such as Stride, Strategic Education, and Adtalem Global Education. According to TipRanks, Silber has an average return of 6.0% and a 54.07% success rate on recommended stocks.
In addition to BMO Capital, AMN Healthcare Services also received a Buy from Citizens JMP’s Constantine Davides in a report issued on November 7. However, today, Benchmark Co. maintained a Hold rating on AMN Healthcare Services (NYSE: AMN).

